TR200907338A1 - Doğal bileşenler içeren bir film şeridi. - Google Patents

Doğal bileşenler içeren bir film şeridi.

Info

Publication number
TR200907338A1
TR200907338A1 TR2009/07338A TR200907338A TR200907338A1 TR 200907338 A1 TR200907338 A1 TR 200907338A1 TR 2009/07338 A TR2009/07338 A TR 2009/07338A TR 200907338 A TR200907338 A TR 200907338A TR 200907338 A1 TR200907338 A1 TR 200907338A1
Authority
TR
Turkey
Prior art keywords
containing natural
film strip
natural ingredients
strip containing
oral mucosa
Prior art date
Application number
TR2009/07338A
Other languages
English (en)
Inventor
Ye��Lada Erdem
Duman G�Leng�L
Original Assignee
Yed�Tepe �N�Vers�Tes�
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yed�Tepe �N�Vers�Tes� filed Critical Yed�Tepe �N�Vers�Tes�
Priority to TR2009/07338A priority Critical patent/TR200907338A1/tr
Priority to PCT/IB2010/054121 priority patent/WO2011036599A1/en
Priority to JP2012531521A priority patent/JP2013505981A/ja
Priority to EP10760438A priority patent/EP2482808A1/en
Publication of TR200907338A1 publication Critical patent/TR200907338A1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/719—Pullulans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Obesity (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

Bu buluş, doğal ürün formulasyonları içeren ve ağız mukozasından emilebilen film şeritleri ile ilgilidir. Söz konusu film şeridi ağız mukozasından bilinen dozaj şekillerine göre daha düşük dozlarda uygulandığında hızla emilerek kısa sürede rahatsızlıkları önleme ve tedavi etme amaçlı kullanılabilmektedir.
TR2009/07338A 2009-09-28 2009-09-28 Doğal bileşenler içeren bir film şeridi. TR200907338A1 (tr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
TR2009/07338A TR200907338A1 (tr) 2009-09-28 2009-09-28 Doğal bileşenler içeren bir film şeridi.
PCT/IB2010/054121 WO2011036599A1 (en) 2009-09-28 2010-09-14 A dissolvable film strip comprising natural components
JP2012531521A JP2013505981A (ja) 2009-09-28 2010-09-14 天然成分を含む溶解可能なフィルムストリップ
EP10760438A EP2482808A1 (en) 2009-09-28 2010-09-14 A dissolvable film strip comprising natural components

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2009/07338A TR200907338A1 (tr) 2009-09-28 2009-09-28 Doğal bileşenler içeren bir film şeridi.

Publications (1)

Publication Number Publication Date
TR200907338A1 true TR200907338A1 (tr) 2011-04-21

Family

ID=43297154

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2009/07338A TR200907338A1 (tr) 2009-09-28 2009-09-28 Doğal bileşenler içeren bir film şeridi.

Country Status (4)

Country Link
EP (1) EP2482808A1 (tr)
JP (1) JP2013505981A (tr)
TR (1) TR200907338A1 (tr)
WO (1) WO2011036599A1 (tr)

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6393717A (ja) 1986-10-09 1988-04-25 Sekisui Chem Co Ltd 口腔粘膜用粘着剤もしくは接着剤
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
JP3370561B2 (ja) * 1997-06-19 2003-01-27 典子 金城 メラトニンの抽出方法
US20030211136A1 (en) * 1998-09-25 2003-11-13 Neema Kulkarni Fast dissolving orally consumable films containing a sweetener
US6596298B2 (en) * 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
GB9904049D0 (en) * 1999-02-22 1999-04-14 Quadrant Holdings Cambridge Rapidly-soluble compositions
ATE346059T1 (de) * 1999-08-16 2006-12-15 Dsm Ip Assets Bv Verfahren zu herstellung von epigallocatechin gallate
JP2001097872A (ja) * 1999-09-30 2001-04-10 Api Co Ltd 赤ブドウ抽出物及びその製造方法
US7067116B1 (en) * 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
US8283135B2 (en) * 2000-06-30 2012-10-09 The Procter & Gamble Company Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
JP4776233B2 (ja) * 2002-11-12 2011-09-21 エラン ファーマ インターナショナル，リミティド 摩損しにくくかつプルランを含む速崩壊性固形製剤
WO2005082407A1 (en) * 2003-11-03 2005-09-09 Musc Foundation For Research Development Use of quercetin and resveratrol to treat and prevent oral cancer
CN100366294C (zh) * 2004-04-30 2008-02-06 量子高科（北京）研究院有限公司 一种口腔速溶制剂及其生产方法
JP2008503580A (ja) * 2004-06-22 2008-02-07 イーエルシー マネージメント エルエルシー 可溶性フィルム組成物
US20090047347A1 (en) * 2005-07-29 2009-02-19 Aegis Therapeutics, Inc. Compositions for Drug Administration
EP2114384A4 (en) * 2007-02-15 2012-02-01 Derma Young Ltd COMPOSITIONS AND METHODS FOR ENHANCING TRANSMUCTIVE ADMINISTRATION
US20080220029A1 (en) * 2007-03-05 2008-09-11 Charlene Ng Fast-dissolving/disintegrating film preparation having high proportion of active
US20100119601A1 (en) * 2007-04-11 2010-05-13 Pharmaceutical Productions Inc. Melatonin tablet and methods of preparation and use
JP2008303153A (ja) * 2007-06-05 2008-12-18 Tsukioka:Kk 生薬製剤
US20090004254A1 (en) 2007-06-19 2009-01-01 Todd Maibach Film comprising active drugs
US20100261784A1 (en) * 2007-12-07 2010-10-14 Fujifilm Corporation Agent for reducing intestinal toxic bacterium and food or pharmaceutical preparation comprising the same
AU2009204181A1 (en) * 2008-01-08 2009-07-16 David Rubin Method and compositions for administering resveratrol and pterostilbene

Also Published As

Publication number Publication date
JP2013505981A (ja) 2013-02-21
EP2482808A1 (en) 2012-08-08
WO2011036599A1 (en) 2011-03-31

Similar Documents

Publication Publication Date Title
CY1123470T1 (el) Αναστολεις ιβατ για την αγωγη ηπατοπαθειων
PH12017501306A1 (en) Inhibitors of histone demethylases
CO6511219A2 (es) Composiciones de película sublinguales y bucales
CY1118813T1 (el) Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων
UA103915C2 (ru) Твердая лекарственная форма, которая содержит линаглиптин и ингибитор sglt2, и ее применение
EA201500742A1 (ru) Защищенные от нецелевого использования фармацевтические композиции
CY1114988T1 (el) Βενζοδιαζεπινη αναστολεας bromodomain
MX350046B (es) Tratamientos para trastornos gastrointestinales.
EP2528934A4 (en) AROMATIC-CATIONIC PEPTIDES AND USES THEREOF
UA111343C2 (uk) Фармацевтична композиція, що містить мометазону фуроат та азеластину гідрохлорид, для назального введення
JOP20130236B1 (ar) تركيبات صيدلانية تشتمل على مثبط b-raf ومثبط egfr ومثبط اختياري لــpi3k alpha
CL2017003066A1 (es) Composiciones de carbonato de calcio amorfo para administración mediante inhalación, sublingual o bucal
PH12012500754A1 (en) Pharmaceutical composition comprising oligopeptides
EA200802324A1 (ru) Новая форма введения рацекадотрила
CY1115081T1 (el) Νεο εκχυλισμα απο γαϊδουραγκαθο, μεθοδος για την παρασκευη και η χρηση του
IN2015DN00376A (tr)
NZ702930A (en) Racecadotril liquid compositions
CR11744A (es) Formulacion liquida para deferiprona con gusto agradable al paladar
UY33530A (es) Composiciones farmacéuticas para el tratamiento de enfermedades respiratorias e inflamatorias
TR201107481A1 (tr) Vildagliptinin efervesan formülasyonları.
TR201906685T4 (tr) Kristalin macitentan içeren farmasötik bileşim.
UY34065A (es) Composición farmacéutica que contiene volasertib en dosificación mejorada y sus usos contra malignidades sólidas
CY1122935T1 (el) Ενισχυτικα της υδατοδιαλυτοτητας που βασιζονται στο γλυκογονο
MX2015007678A (es) Liberacion transmucosa de acetato de glatiramero por medio de tabletas orales.
TR200907917A2 (tr) Kuru toz inhaleri.